GLP-1 receptor agonists such as semaglutide and tirzepatide are FDA-regulated for chronic weight management in adults with a BMI of 30 or higher, or 27 with a weight-related condition. Las Vegas runs around the clock, and dealers, servers, performers and resort staff working overnight and rotating shifts rarely fit a daytime clinic into their week - even as the job keeps appearance and stamina front of mind. Telehealth works on their clock: a licensed Nevada physician reviews your online assessment under Nevada Revised Statutes §629.515, and compounded medication from an FDA-registered 503B pharmacy ships to your Las Vegas address. Monthly cost runs $199–$379 versus about $1,247 for brand-name Ozempic or Wegovy. Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Serving Las Vegas ZIP codes: 89101, 89102, 89104, 89109, 89119.
Local clinics serving Henderson 89014: Nevada Weight Loss Wellness. Many patients compare these in-person options against licensed GLP-1 telehealth — prescribed online, shipped to the door.
Semaglutide in Henderson 89014: local pointers and concrete answers. Originally developed for type 2 diabetes as Ozempic, semaglutide was reformulated at a higher dose as Wegovy specifically for weight management.
The monthly cost depends mostly on the format you choose: the brand-name version without insurance is by far the most expensive, while compounded telehealth formulas cut the bill sharply. Some compounding pharmacies bill per vial, others per full program - comparing the 'all-in' cost avoids surprises at refill time.
With a local obesity rate around 30.6% and 11.0% uninsured, demand for Semaglutide runs high around Henderson 89014. Local landmark: Nevada Weight Loss Wellness (2501 N Green Valley Pkwy Suite 101D, Henderson, NV 89014), rated 5/5 across 2 reviews. Semaglutide belongs to the 'GLP-1 receptor agonist (incretin analog)' class and is given as a weekly subcutaneous injection. Around Henderson 89014 in Clark County, 1 weight-management practice(s) are listed locally.
Most patients notice reduced appetite within the first 1-2 weeks; clinically meaningful weight loss usually appears between week 8 and week 12 as the dose increases.
Coverage varies by plan and indication; many patients without coverage opt for a compounded formula at a fixed monthly cost.
Ozempic is a brand of semaglutide dosed for diabetes; Wegovy is the same active ingredient dosed for weight loss. Semaglutide is the shared generic molecule.
Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Licensed in Nevada. All prescriptions issued under Nevada Revised Statutes §629.515 and supervised by Nevada State Board of Medical Examiners.